138 related articles for article (PubMed ID: 7530271)
1. Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain.
Jones DA; Hunt SW; Prisayanh PS; Briggaman RA; Gammon WR
J Invest Dermatol; 1995 Feb; 104(2):231-5. PubMed ID: 7530271
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain.
Gammon WR; Murrell DF; Jenison MW; Padilla KM; Prisayanh PS; Jones DA; Briggaman RA; Hunt SW
J Invest Dermatol; 1993 May; 100(5):618-22. PubMed ID: 7684054
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa.
Lapiere JC; Woodley DT; Parente MG; Iwasaki T; Wynn KC; Christiano AM; Uitto J
J Clin Invest; 1993 Oct; 92(4):1831-9. PubMed ID: 7691888
[TBL] [Abstract][Full Text] [Related]
4. Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita.
Chen M; Chan LS; Cai X; O'Toole EA; Sample JC; Woodley DT
J Invest Dermatol; 1997 Jan; 108(1):68-72. PubMed ID: 8980290
[TBL] [Abstract][Full Text] [Related]
5. The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita.
Chen M; Doostan A; Bandyopadhyay P; Remington J; Wang X; Hou Y; Liu Z; Woodley DT
Am J Pathol; 2007 Jun; 170(6):2009-18. PubMed ID: 17525268
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and characterization of a cDNA encoding canine type VII collagen non-collagenous (NC1) domain, the target antigen of autoimmune disease epidermolysis bullosa acquisita (EBA).
Xu L; Chen M; Peng J; O'Toole EA; Woodley DT; Chan LS
Biochim Biophys Acta; 1998 Oct; 1408(1):25-34. PubMed ID: 9784596
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype.
Gandhi K; Chen M; Aasi S; Lapiere JC; Woodley DT; Chan LS
J Clin Immunol; 2000 Nov; 20(6):416-23. PubMed ID: 11202231
[TBL] [Abstract][Full Text] [Related]
8. A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen.
Tanaka H; Ishida-Yamamoto A; Hashimoto T; Hiramoto K; Harada T; Kawachi Y; Shimizu H; Tanaka T; Kishiyama K; Höpfner B; Takahashi H; Iizuka H; Bruckner-Tuderman L
Lab Invest; 1997 Dec; 77(6):623-32. PubMed ID: 9426400
[TBL] [Abstract][Full Text] [Related]
9. The lupus band: do the autoantibodies target collagen VII?
Alahlafi AM; Wordsworth P; Wojnarowska F
Br J Dermatol; 2004 Mar; 150(3):504-10. PubMed ID: 15030334
[TBL] [Abstract][Full Text] [Related]
10. Noncollagenous (NC1) domain of collagen VII resembles multidomain adhesion proteins involved in tissue-specific organization of extracellular matrix.
Gammon WR; Abernethy ML; Padilla KM; Prisayanh PS; Cook ME; Wright J; Briggaman RA; Hunt SW
J Invest Dermatol; 1992 Dec; 99(6):691-6. PubMed ID: 1469284
[TBL] [Abstract][Full Text] [Related]
11. The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis Bullosa acquisita autoantibodies.
Chen M; Keene DR; Costa FK; Tahk SH; Woodley DT
J Biol Chem; 2001 Jun; 276(24):21649-55. PubMed ID: 11274208
[TBL] [Abstract][Full Text] [Related]
12. Epitope mapping for epidermolysis bullosa acquisita autoantibody by molecularly cloned cDNA for type VII collagen.
Tanaka T; Furukawa F; Imamura S
J Invest Dermatol; 1994 May; 102(5):706-9. PubMed ID: 7513737
[TBL] [Abstract][Full Text] [Related]
13. A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading.
Fairley JA; Woodley DT; Chen M; Giudice GJ; Lin MS
J Am Acad Dermatol; 2004 Jul; 51(1):118-22. PubMed ID: 15243536
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti-type VII collagen autoantibodies: an Italian multicentre study.
Marzano AV; Cozzani E; Fanoni D; De Pità O; Vassallo C; Berti E; Parodi A; Crosti C; Cugno M
Br J Dermatol; 2013 Jan; 168(1):80-4. PubMed ID: 22913489
[TBL] [Abstract][Full Text] [Related]
15. NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats.
Chen M; Marinkovich MP; Jones JC; O'Toole EA; Li YY; Woodley DT
J Invest Dermatol; 1999 Feb; 112(2):177-83. PubMed ID: 9989793
[TBL] [Abstract][Full Text] [Related]
16. Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients.
Saleh MA; Ishii K; Kim YJ; Murakami A; Ishii N; Hashimoto T; Schmidt E; Zillikens D; Shirakata Y; Hashimoto K; Kitajima Y; Amagai M
J Dermatol Sci; 2011 Jun; 62(3):169-75. PubMed ID: 21482078
[TBL] [Abstract][Full Text] [Related]
17. Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated.
Gammon WR; Heise ER; Burke WA; Fine JD; Woodley DT; Briggaman RA
J Invest Dermatol; 1988 Sep; 91(3):228-32. PubMed ID: 3137269
[TBL] [Abstract][Full Text] [Related]
18. Autoimmunity to type VII collagen in SKH1 mice is independent of regulatory T cells.
Chen L; Peterson JD; Zheng WY; Lin SX; Chan LS
Clin Exp Immunol; 2006 Aug; 145(2):322-31. PubMed ID: 16879253
[TBL] [Abstract][Full Text] [Related]
19. The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain.
Netzer KO; Leinonen A; Boutaud A; Borza DB; Todd P; Gunwar S; Langeveld JP; Hudson BG
J Biol Chem; 1999 Apr; 274(16):11267-74. PubMed ID: 10196215
[TBL] [Abstract][Full Text] [Related]
20. Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature.
Mayuzumi M; Akiyama M; Nishie W; Ukae S; Abe M; Sawamura D; Hashimoto T; Shimizu H
Br J Dermatol; 2006 Nov; 155(5):1048-52. PubMed ID: 17034540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
